Strålbehandling/ Forskargrupp Strålbehandling – Pehr Lind Forskargrupp

Publikationer

Alla gruppmedlemmars publikationer

• Journal article: RADIOTHERAPY AND ONCOLOGY. 2025;206:s1170-s1173

  1489 STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer

  Marijnen CAM; Sebag-Montefiore D; Homer V; Gates S; Al-Najami I; Angenete E; Appelt A; Baatrup G; Beets G; Burger JWA; Spindler K-LG; Geh I; Gilbert A; Haustermans K; Holman F; Korsgen S; Lind P; Martling A; Peters F; Teo M; West N; Wolthuis A; de Wilt JWH; ESTRO SPBSCLG
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2025;206:S1170-S1173

  STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer

  Marijnen CAM; Sebag-Montefiore D; Homer V; Gates S; Al-Najami I; Angenete E; Appelt A; Baatrup G; Beets G; Burger JWA; Spindler K-LG; Geh I; Gilbert A; Haustermans K; Holman F; Korsgen S; Lind P; Martling A; Peters F; Teo M; West N; Wolthuis A; de Wilt JWH; Bach SP
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;43(10):JCO2401118-1253

  Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

  Palmer DH; Jackson R; Springfeld C; Ghaneh P; Rawcliffe C; Halloran CM; Faluyi O; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Lind P; Glimelius B; Falk S; Ma YT; Middleton GW; Cummins S; Ross PJ; Wasan H; Mcdonald A; Crosby T; Hammel P; Borg D; Sothi S; Valle JW; Mehrabi A; Bailey P; Tjaden C; Michalski C; Hackert T; Buechler MW; Neoptolemos JP
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16_suppl):e15615

  Bowel bag sparing in palliative radiotherapy (pRT) of rectal cancer (rCa): Tradeoff between organs at risk (OARs) and use of AI to reduce radiation oncologist (RO) workload.

  Fredén E; Knutsson J; Yousif R; Siegbahn A; Lind PA
• Journal article: RADIOTHERAPY AND ONCOLOGY. 2024;194:s1491-s1493

  723: Delineation variations in RT planning of rectum cancer patients using the Swedish guideline

  Fredén E; Knutsson J; Lagerbäck C; Siegbahn A; Lind P
• Article: JOURNAL OF SURGICAL ONCOLOGY. 2024;129(4):734-744

  The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial

  Caspers IA; Slagter AE; Lind P; Sikorska K; Wiklund K; Ponten F; Nordsmark M; van de Velde CJH; Kranenbarg EM-K; van Sandick JW; Jansen EPM; van Laarhoven HWM; Verheij M; van Grieken NCT; Cats A
• Doctoral thesis: 2024

  Radiation-induced toxicity and secondary malignant neoplasms in radiotherapy of intrathoracic tumors

  Lideståhl A
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)

  Bowel bag sparing in palliative radiotherapy (pRT) of rectal cancer (rCa): Tradeoff between organs at risk (OARs) and use of AI to reduce radiation oncologist (RO) workload

  Freden E; Knutsson J; Yousif R; Siegbahn A; Lind PA
• Article: GASTRIC CANCER. 2024;27(1):102-109

  Effect of preoperative chemotherapy on the histopathological classification of gastric cancer

  Caspers IA; Biesma HD; Wiklund K; Ponten F; Lind P; Nordsmark M; Sikorska K; Meershoek-KleinKranenbarg E; Hartgrink HH; van de Velde CJH; van Sandick JW; Verheij M; Cats A; van Grieken NCT
• Article: CANCERS. 2023;15(24):5736

  Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer

  Lidestahl A; Freden E; Siegbahn A; Johansson G; Lind PA; Ishikawa E; Matschke J; Rueckert M; Deloch L
• Journal article: JOURNAL OF RADIOTHERAPY IN PRACTICE. 2022;21(4):455-461

  Changes on myocardial perfusion scintigraphy and contrast-enhanced cardiac magnetic resonance imaging after definitive radiotherapy in patients with lung cancer

  Lidestahl A; Larsson T; Thoren L; Brodin O; Lind PA
• Article: MEDICAL PHYSICS. 2022;49(8):5589-5603

  Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model

  Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
• Article: CANCERS. 2022;14(12):2963

  Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer

  Slagter AE; Caspers IA; van Grieken NCT; Walraven I; Lind P; Meershoek-Klein Kranenbarg E; Grootscholten C; Nordsmark M; van Sandick JW; Sikorska K; van de Velde CJH; Jansen EPM; Verheij M; van Laarhoven HWM; Cats A
• Journal article: RADIOTHERAPY AND ONCOLOGY. 2022;170:s1255-s1256

  PO-1480 Heart dose variability in RT of left breast cancer patients treated in deep inspiration breath hold

  Johansson G; Fredén E; Knutsson J; Olin M; Dagertun L; Siegbahn A
• Review: ACTA ONCOLOGICA. 2022;61(4):523-530

  Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives

  Merk C; Martling A; Lindberg J; Benhaim L; Taieb J; Lind P
• Article: GASTRIC CANCER. 2022;25(2):401-410

  Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial

  Slagter AE; Vollebergh MA; Caspers IA; van Sandick JW; Sikorska K; Lind P; Nordsmark M; Putter H; Braak JPBM; Kranenbarg EM-K; van de Velde CJH; Jansen EPM; Cats A; van Laarhoven HWM; van Grieken NCT; Verheij M
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2022;170:S1255-S1256

  Heart dose variability in RT of left breast cancer patients treated in deep inspiration breath hold

  Johansson G; Freden E; Knutsson J; Olin M; Dagertun L; Siegbahn A
• Article: CANCERS. 2021;13(20):5153

  Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams

  Lidestahl A; Johansson G; Siegbahn A; Lind PA
• Article: CANCERS. 2021;13(18):4626

  Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial

  Caspers IA; Sikorska K; Slagter AE; van Amelsfoort RM; Kranenbarg EM-K; van de Velde CJH; Lind P; Nordsmark M; Jansen EPM; Verheij M; van Sandick JW; Cats A; van Grieken NCT
• Journal article: RADIOTHERAPY AND ONCOLOGY. 2021;161:s1513-s1514

  PO-1788 Estimated risk of radiation-induced cancer after thymoma treatments with proton- or x-ray beams

  Lideståhl A; Johansson G; Siegbahn A; Lind PA
• Journal article: RADIOTHERAPY AND ONCOLOGY. 2021;161:s1490-s1492

  PO-1764 Evaluation of the setup accuracy of a surface scanning system in radiotherapy of breast cancer

  Knutsson J; Johansson G; Dagertun L; Olin M; Siegbahn A
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(15):4053

  Risk factors of metachronous peritoneal carcinomatosis after potentially curative gastric cancer resection in the CRITICS trial.

  Caspers IA; Sikorska K; Slagter AE; Kranenbarg EM-K; Van de Velde CJH; Lind PA; Nordsmark M; Jansen EPM; Verheij M; van Sandick JW; Cats A; van Grieken NCT
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(15_suppl):4024

  The prognostic value of tumor markers in patients (pts) with resectable gastric cancer (GC) receiving perioperative therapy in the CRITICS trial.

  Slagter AE; Vollebergh MA; Caspers IA; van Sandick JW; Sikorska K; Lind PA; Nordsmark M; Putter H; Braak JPBM; Kranenbarg EM; Van De Velde CJH; Jansen EP; Cats A; Van Laarhoven HWM; van Grieken NCT; Verheij M
• Article: ANNALS OF ONCOLOGY. 2021;32(3):360-367

  Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial

  de Steur WO; van Amelsfoort RM; Hartgrink HH; Putter H; Kranenbarg EM-K; van Grieken NCT; van Sandick JW; Claassen YHM; Braak JPBM; Jansen EPM; Sikorska K; van Tinteren H; Walraven I; Lind P; Nordsmark M; Henegouwen MIVB; van Laarhoven HWM; Cats A; Verheij M; van de Velde CJH
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2021;161:S1513-S1514

  Estimated risk of radiation-induced cancer after thymoma treatments with proton- or x-ray beams

  Lidestahl A; Johansson G; Siegbahn A; Lind PA
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2021;161:S306-S307

  The prognostic value of tumor markers in patients with resectable gastric cancer

  Slagter A; Vollebergh M; Caspers I; van Sandick J; Sikorska K; Lind P; Nordsmark M; Putter H; Braak J; Kranenbarg EM-K; van de Velde C; Jansen E; Cats A; van Laarhoven H; van Grieken N; Verheij M
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2021;161:S1490-S1492

  Evaluation of the setup accuracy of a surface scanning system in radiotherapy of breast cancer

  Knutsson J; Johansson G; Dagertun L; Olin M; Siegbahn A
• Article: CANCER MEDICINE. 2020;9(18):6609-6616

  Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial

  Slagter AE; Sikorska K; Grootscholten C; van Laarhoven HWM; Lind P; Nordsmark M; Kranenbarg EM-K; van de Velde CJH; van Grieken NCT; van Sandick JW; Jansen EPM; Verheij M; Cats A
• Article: EUROPEAN JOURNAL OF CANCER. 2020;130:146-154

  Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial

  Slagter AE; Tudela B; van Amelsfoort RM; Sikorska K; van Sandick JW; van de Velde CJH; van Grieken NCT; Lind P; Nordsmark M; Putter H; Hulshof MCCM; van Laarhoven HWM; Grootscholten C; Braak JPBM; Kranenbarg EM-K; Jansen EPM; Cats A; Verheij M
• Journal article: EJSO. 2020;46(2):e17

  Patterns of recurrence in the CRITICS gastric cancer trial: results from intention-to-treat and per-protocol analyses

  De Steur W; Van Amelsfoort R; Putter H; Hartgrink H; Sikorska K; Cats A; van Grieken N; Kranenbarg EM-K; van Sandick J; Lind P; Norsmark M; Verheij M; van de Vede C
• Article: SCIENTIFIC REPORTS. 2019;9(1):17082

  Locomotion and eating behavior changes in Yucatan minipigs after unilateral radio-induced ablation of the caudate nucleus

  Coquery N; Adam J-F; Nemoz C; Janvier R; Livingstone J; Chauvin A; Kefs S; Guerineau C; De Saint Jean L; Ocadiz A; Bouchet A; Bartzsch S; Schueltke E; Siegbahn A; Brauer-Krisch E; Lemasson B; Barbier EL; Laissue J; Balosso J; Val-Laillet D; Serduc R
• Article: JAMA SURGERY. 2019;154(11):1038-1048

  Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

  Jones RP; Psarelli E-E; Jackson R; Ghaneh P; Halloran CM; Palmer DH; Campbell F; Valle JW; Faluyi O; O'Reilly DA; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Anthoney A; Lind P; Glimelius B; Falk S; Izbicki JR; Middleton GW; Cummins S; Ross PJ; Wasan H; McDonald A; Crosby T; Ting Y; Patel K; Sherriff D; Soomal R; Borg D; Sothi S; Hammel P; Lerch MM; Mayerle J; Tjaden C; Strobel O; Hackert T; Buchler MW; Neoptolemos JP; Hill M; Corrie P; Hickish T; Napier M; Slater S; Valle J; Shablak A; Cunnell M; Guimbaud R; Roques T; Iveson T; Jamil A; Robinson A; Garcia-Alonso A; Chang D; Tsang D; Wadd N; Wall L; Nielsen NH; Lerch M; Mehta A; Sivaramalingam M; Fyfe D; Osborne R; Blesing C; Bulusu VR; Rathbone E; Seitz J-F; Beaumont E; Dernedde U; McAdam K; Dimopoulos P; Cominos M; Askill C; Piwowar A; Bachet J-B; Sumpter K; Raouf S; Nicoll J; Rees C; Dhinakaran K; Haux J; Bengrine-Lefevre L; Terrebonne E; Shankland C; Palmer C; Medley L; Toy E; Kaur J; Gupta K; Cheeseman S; Patterson D; Candish C; Thompson J; Coxon F; Connolly C; McPhail N; Williams R; Flygare P; Elmlund M; Artru P; Millat B
• Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2019;105(1):E210

  Perioperative Therapy with Postoperative Chemoradiotherapy in the Critics Gastric Cancer Trial: A Comparison of Elderly Versus Non-Elderly Patients

  Slagter AE; Tudela B; van Amelsfoort RM; Sikorska K; Sandick JW; van de Velde CJ; van Grieken NC; Lind PA; Nordsmark M; Putter H; van Laarhoven HW; Grootscholten C; Kranenbarg EM-K; Jansen EPM; Cats A; Verheij M
• Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2019;105(1):S86

  Patterns of Recurrence in the Critics Gastric Cancer Trial: Results from Intention-to-Treat and per-Protocol Analyses

  van Amelsfoort RM; de Steur W; Sikorska K; Jansen EPM; Cats A; van Grieken NC; Boot H; Lind PA; Kranenbarg EM-K; Nordsmark M; Hartgrink H; Putter H; Trip AK; Sandick JW; van Tinteren H; Claassen YHM; Braak JPBM; van Laarhoven HW; van de Velde CJ; Verheij M
• Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2019;60:120-126

  An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours

  Lidestahl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(4):81

  A comparison of elderly versus nonelderly patients in the CRITICS gastric cancer trial.

  Slagter AE; Tudela B; van Amelsfoort R; Sikorska K; van Sandick JW; De Velde CJHV; van Grieken NCT; Lind PA; Nordsmark M; Putter H; Kranenbarg EM-K; Edwin PM
• Article: RADIATION ONCOLOGY. 2018;13(1):206

  Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases

  Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(15):4060

  Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer.

  Van Amelsfoort R; Walraven I; Jansen EPM; Cats A; van Grieken NCT; Aaronson NK; Boot H; Lind PA; Kranenbarg EM-K; Nordsmark M; Putter H; Trip AK; van Sandick JW; Sikorska K; van Tinteren H; Van De Velde CJH; Verheij M
• Article: ANTICANCER RESEARCH. 2018;38(5):2619-2625

  Estimation of Risk of Normal-tissue Toxicity Following Gastric Cancer Radiotherapy with Photon- or Scanned Proton-beams

  Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
• Article: LANCET ONCOLOGY. 2018;19(5):616-628

  Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

  Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Kranenbarg EM-K; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; Henegouwen MIVB; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2018;127:S86-S87

  Patterns of recurrence in the CRITICS gastric cancer phase III trial

  Verheij M; Van Amelsfoort R; Sikorska K; Jansen E; Cats A; Van Grieken N; Boot H; Lind P; Kranenbarg EM-K; Nordsmark M; Hartgrink H; Putter H; Trip A; Van Sandick J; Van Tinteren H; Claassen Y; Braak J; Van de Velde C
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2018;127:S1092-S1093

  Normal-tissue toxicity following gastric cancer radiotherapy with photon- or scanned proton-beams

  Mondlane GA; Ureba A; Gubanski M; Lind P; Siegbahn A
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2018;127:S1202-S1203

  dosimetric evaluation of carbon-ion beam grid therapy of brain tumors

  Tsubouchi T; Valdman A; Siegbahn A
• Article: MEDICAL PHYSICS. 2018;45(3):1210-1221

  Quantitative evaluation of potential irradiation geometries for carbon-ion beam grid therapy

  Tsubouchi T; Henry T; Ureba A; Valdman A; Bassler N; Siegbahn A
• Article: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2017;16(6):749-757

  Proton Grid Therapy: A Proof-of-Concept Study

  Henry T; Ureba A; Valdman A; Siegbahn A
• Published conference paper: ACTA ONCOLOGICA. 2017;56(11):1437-1443

  Development of an interlaced-crossfiring geometry for proton grid therapy

  Henry T; Bassler N; Ureba A; Tsubouchi T; Valdman A; Siegbahn A
• Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2017;42:263-270

  Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases

  Mondlane G; Gubanski M; Lind PA; Ureba A; Siegbahn A
• Journal article: PANCREATOLOGY. 2017;17(3):s75

  Current Treatment Reality of Pancreatic Adenocarcinoma

  Kordes M; Liljefors MG; Karimi M; Lind P; Frödin J-E; Löhr M
• Published conference paper: ACTA ONCOLOGICA. 2017;56(6):832-838

  Comparison of gastric-cancer radiotherapy performed with volumetric modulated arc therapy or single-field uniform-dose proton therapy

  Mondlane G; Gubanski M; Lind PA; Ureba A; Siegbahn A
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2017;123:S959

  Evaluation of proton grid therapy in challenging clinical cases

  Henry T; Valdman A; Siegbahn A
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2017;123:S953

  Proton grid therapy (PGT): a parameter study

  Henry T; Valdman A; Siegbahn A
• Article: LANCET. 2017;389(10073):1011-1024

  Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

  Neoptolemos JP; Palmer DH; Ghaneh P; Psarelli EE; Valle JW; Halloran CM; Faluyi O; O'Reilly DA; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Anthoney A; Lind P; Glimelius B; Falk S; Izbicki JR; Middleton GW; Cummins S; Ross PJ; Wasan H; McDonald A; Crosby T; Ma YT; Patel K; Sherriff D; Soomal R; Borg D; Sothi S; Hammel P; Hackert T; Jackson R; Buechler MW
• Journal article: MEDICAL PHYSICS. 2016;43(8Part2):4939

  Poster ‐ 15: Air kerma rate measurements using a cylindrical free‐air ionization chamber on the 05B1‐1 beamline at the Canadian Light Source

  Anderson D; Siegbahn A; Fallone G; Warkentin B
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):4000

  A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study

  Verheij M; Jansen EPM; Cats A; van Grieken NCT; Aaronson NK; Boot H; Lind PA; Kranenbarg EM-K; Nordsmark M; Putter H; Trip AK; van Sandick JW; Sikorska K; van Tinteren H; Van de Velde CJH
• Article: PRACTICAL RADIATION ONCOLOGY. 2016;6(3):e53-e59

  Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer

  von Dobeln GA; Nilsson M; Adell G; Johnsen G; Hatlevoll I; Tsai J; Lundell L; Lund M; Lind P
• Conference publication: RADIOTHERAPY AND ONCOLOGY. 2016;119:S260

  The development of proton-beam grid therapy (PBGT)

  Henry T; Valdman A; Siegbahn A
• Article: ANNALS OF ONCOLOGY. 2016;27(4):660-667

  A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction

  Klevebro F; von Dobeln GA; Wang N; Johnsen G; Jacobsen A-B; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M
• Conference publication: PANCREAS. 2016;45(10):1529

  ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma

  Neoptolemos JP; Palmer D; Ghaneh P; Valle J; Cunningham D; Wadsley J; Meyer T; Anthoney A; Glimelius B; Falk S; Lind P; Izbicki J; Middleton G; Ross P; Wasan H; McDonald A; Crosby T; Psarelli E; Hammel P; Buechler MW
• Article: INTERNATIONAL JOURNAL OF PARTICLE THERAPY. 2016;3(2):277-284

  Dosimetric Comparison of Plans for Photon- or Proton-Beam Based Radiosurgery of Liver Metastases.

  Mondlane G; Gubanski M; Lind PA; Henry T; Ureba A; Siegbahn A
• Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2015;31(6):568-583

  Medical physics aspects of the synchrotron radiation therapies: Microbeam radiation therapy (MRT) and synchrotron stereotactic radiotherapy (SSRT)

  Braeuer-Krisch E; Adam J-F; Alagoz E; Bartzsch S; Crosbie J; DeWagter C; Dipuglia A; Donzelli M; Doran S; Fournier P; Kalef-Ezra J; Kock A; Lerch M; McErlean C; Oelfke U; Olko P; Petasecca M; Povoli M; Rosenfeld A; Siegbahn EA; Sporea D; Stugu B
• Review: CLINICAL GENITOURINARY CANCER. 2015;13(4):280-286

  Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

  Nearchou A; Valachis A; Lind P; Akre O; Sandstrom P
• Review: EJSO. 2015;41(3):282-294

  Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: A direct and adjusted indirect comparison meta-analysis

  Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Lind PA; Lindblad M; Ye W; Lundell L; Schuhmacher C; Mauer M; Burmeister BH; Thomas JM; Stahl M; Nilsson M
• Article: ACTA ONCOLOGICA. 2014;53(10):1373-1379

  Long-term functional and radiological pulmonary changes after radiation therapy for breast cancer

  Goldman UB; Svane G; Anderson M; Wennberg B; Lind P
• Article: JOURNAL OF SYNCHROTRON RADIATION. 2014;21(Pt 4):801-810

  Spatial and temporal distribution of γH2AX fluorescence in human cell cultures following synchrotron-generated X-ray microbeams: lack of correlation between persistent γH2AX foci and apoptosis

  Anderson DL; Mirzayans R; Andrais B; Siegbahn EA; Fallone BG; Warkentin B
• Article: JOURNAL OF RADIOTHERAPY IN PRACTICE. 2014;13(2):211-217

  Radiation pneumonitis and pulmonary function with lung dose-volume constraints in breast cancer irradiation

  Goldman UB; Anderson M; Wennberg B; Lind P
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(15):e15567

  Acquired hypothyroidism as a predictive marker of outcome in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine-kinase inhibitors (TKIs): A literature-based meta-analysis

  Nearchou AD; Valachis A; Lind PA; Akre O; Sandstrom P
• Article: MEDICAL ONCOLOGY. 2014;31(4):906

  Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)

  Gubanski M; Glimelius B; Lind PA
• Review: BREAST CANCER RESEARCH AND TREATMENT. 2014;144(3):443-455

  Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis

  Valachis A; Nearchou AD; Lind P
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(6):504-512

  Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

  Valle JW; Palmer D; Jackson R; Cox T; Neoptolemos JP; Ghaneh P; Rawcliffe CL; Bassi C; Stocken DD; Cunningham D; O'Reilly D; Goldstein D; Robinson BA; Karapetis C; Scarfe A; Lacaine F; Sand J; Izbicki JR; Mayerle J; Dervenis C; Olah A; Butturini G; Lind PA; Middleton MR; Anthoney A; Sumpter K; Carter R; Buecher MW
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(4):500

  Acquired hypothyroidism as a predictive marker of outcome in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine-kinase inhibitors (TKIs): A literature-based meta-analysis.

  Nearchou AD; Valachis A; Lind P; Akre O; Sandstrom P
• Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(9):2245-2252

  Cardiac toxicity in breast cancer patients treated with dual HER2 blockade

  Valachis A; Nearchou A; Polyzos NP; Lind P
• Article: JOURNAL OF INSTRUMENTATION. 2013;8:C06008

  Comparison of two methods for measuring γ-H2AX nuclear fluorescence as a marker of DNA damage in cultured human cells: applications for microbeam radiation therapy

  Anderson D; Andrais B; Mirzayans R; Siegbahn EA; Fallone BG; Warkentin B
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(15_suppl):624

  Cardiac toxicity in breast cancer patients treated with dual HER2 blockade: A meta-analysis of randomized evidence.

  Valachis A; Nearchou AD; Polyzos NP; Lind P
• Article: ACTA ONCOLOGICA. 2013;52(4):824-830

  Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy

  Hultman B; Lind P; Glimelius B; Sundbom M; Nygren P; Haglund U; Mahteme H
• Review: ONCOLOGIST. 2013;18(4):353-361

  Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis

  Valachis A; Polyzos NP; Coleman RE; Gnant M; Eidtmann H; Brufsky AM; Aft R; Tevaarwerk AJ; Swenson K; Lind P; Mauri D
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(15)

  Cardiac toxicity in breast cancer patients treated with dual HER2 blockade: A meta-analysis of randomized evidence

  Valachis A; Nearchou AD; Polyzos NP; Lind P
• Article: RADIOTHERAPY AND ONCOLOGY. 2013;106(1):106-111

  Response of the rat spinal cord to X-ray microbeams

  Laissue JA; Bartzsch S; Blattmann H; Braeuer-Krisch E; Bravin A; Dallery D; Djonov V; Hanson AL; Hopewell JW; Kaser-Hotz B; Keyrilainen J; Laissue PP; Miura M; Serduc R; Siegbahn AE; Slatkin DN
• Conference publication: CANCER RESEARCH. 2012;72:p5-18-18-p5-18-18

  Lapatinib versus trastuzumab, or both, added to preoperative chemotherapy for breast cancer: A meta-analysis of randomized evidence

  Valachis A; Nearchou A; Lind P
• Letter: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(31):3895

  Role of Financial Relationships in Economic Analyses of Targeted Therapies in Oncology Remains Unclear Reply

  Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
• Review: BREAST CANCER RESEARCH AND TREATMENT. 2012;135(3):655-662

  Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence

  Valachis A; Nearchou A; Lind P; Mauri D
• Meeting abstract: MEDICAL PHYSICS. 2012;39(7):4645

  Evaluation of dose-volume metrics for microbeam radiation therapy

  Anderson D; Siegbahn EA; Fallone BG; Serduc R; Warkentin B
• Article: JOURNAL OF SYNCHROTRON RADIATION. 2012;19(Pt 4):478-482

  Chalcone JAI-51 improves efficacy of synchrotron microbeam radiation therapy of brain tumors

  Bouchet A; Boumendjel A; Khalil E; Serduc R; Braeuer E; Siegbahn EA; Laissue JA; Boutonnat J
• Article: PHYSICS IN MEDICINE AND BIOLOGY. 2012;57(10):3223-3248

  Evaluation of dose-volume metrics for microbeam radiation therapy dose distributions in head phantoms of various sizes using Monte Carlo simulations

  Anderson D; Siegbahn EA; Fallone BG; Serduc R; Warkentin B
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15_suppl):5066

  Effect of BRCA mutation on prognosis in patients with ovarian cancer: A systematic review and meta-analysis.

  Valachis A; Polyzos NP; Zavos A; Mauri D; Lind PA
• Letter: VETERINARY OPHTHALMOLOGY. 2012;15(3):210-211

  A misprint in a description of microbeam irradiations of rats' heads

  Laissue JA; Blattmann H; Siegbahn EA; Slatkin DN
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(12):1316-1320

  Financial Relationships in Economic Analyses of Targeted Therapies in Oncology

  Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15)

  Effect of BRCA mutation on prognosis in patients with ovarian cancer: A systematic review and meta-analysis

  Valachis A; Polyzos NP; Zavos A; Mauri D; Lind PA
• Journal article: CANCER RESEARCH. 2011;71(24_Supplement):p3-07-34-p3-07-34

  P3-07-34: Occult Metastasis in Sentinel Node: Should This Affect the Clinical Decision Making? A Systematic Review and Meta-Analysis.

  Valachis A; Nearchou A; Polyzos N; Lind P; Berqvist J
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2011;81(4):e439-e445

  DELINEATION OF GROSS TUMOR VOLUME (GTV) FOR RADIATION TREATMENT PLANNING OF LOCALLY ADVANCED RECTAL CANCER USING INFORMATION FROM MRI OR FDG-PET/CT: A PROSPECTIVE STUDY

  Braendengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
• Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2011;81(2):S211

  Prognostic Significance of Histologically Proven Residual Tumor following Radical Radiotherapy

  Ljung G; Valachis A; Nearchou A; Lind P; Nilsson S
• Conference publication: EUROPEAN JOURNAL OF CANCER. 2011;47:S377

  Adjuvant Therapy With Zoledronic Acid in Primary Breast Cancer: a Systematic Review and Meta-analysis

  Valachis A; Nearchou A; Polyzos NP; Mauri D; Lind PA
• Article: BMC CANCER. 2011;11:329

  Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)

  Dikken JL; van Sandick JW; Swellengrebel HAM; Lind PA; Putter H; Jansen EPM; Boot H; van Grieken NCT; van de Velde CJH; Verheij M; Cats A
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):1591

  Time since last pregnancy and breast cancer survival: A systematic review and meta-analysis

  Valachis A; Nearchou AD; Mauri D; Lind PA; Polyzos NP
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):6120

  Conflict of interest in economic analyses of targeted therapies in oncology.

  Nearchou AD; Valachis A; Polyzos NP; Mauri D; Lind PA
• Article: NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT. 2011;629(1):345-349

  In-line phase-contrast stereoscopic X-ray imaging for radiological purposes: An initial experimental study

  Siegbahn EA; Coan P; Zhou S-A; Bravin A; Brahme A
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2010;78(5):1503-1512

  PREFERENTIAL EFFECT OF SYNCHROTRON MICROBEAM RADIATION THERAPY ON INTRACEREBRAL 9L GLIOSARCOMA VASCULAR NETWORKS

  Bouchet A; Lemasson B; Le Duc G; Maisin C; Brauer-Krisch E; Siegbahn EA; Renaud L; Khalil E; Remy C; Poillot C; Bravin A; Laissue JA; Barbier EL; Serduc R
• Article: RADIATION ONCOLOGY. 2010;5:99

  Reduction of radiation pneumonitis by V20-constraints in breast cancer

  Goldman UB; Wennberg B; Svane G; Bylund H; Lind P
• Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2010;304(10):1073-1081

  Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial

  Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Olah A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Buechler MW
• Article: GASTRIC CANCER. 2010;13(3):155-161

  Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

  Gubanski M; Johnsson A; Fernebro E; Kadar L; Karlberg I; Flygare P; Berglund A; Glimelius B; Lind PA
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2010;77(5):1545-1552

  TOLERANCE OF ARTERIES TO MICROPLANAR X-RAY BEAMS

  van der Sanden B; Braeuer-Krisch E; Siegbahn EA; Ricard C; Vial J-C; Laissue J
• Conference publication: AIP CONFERENCE PROCEEDINGS. 2010;1266(1):89-97

  Potential High Resolution Dosimeters For MRT

  Bräuer-Krisch E; Rosenfeld A; Lerch M; Petasecca M; Akselrod M; Sykora J; Bartz J; Ptaszkiewicz M; Olko P; Berg A; Wieland M; Doran S; Brochard T; Kamlowski A; Cellere G; Paccagnella A; Siegbahn EA; Prezado Y; Martinez-Rovira I; Bravin A; Dusseau L; Berkvens P; Siu KKW
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2010;77(4):1166-1170

  INTEROBSERVER VARIATION OF CLINICAL TARGET VOLUME DELINEATION IN GASTRIC CANCER

  Jansen EPM; Nijkamp J; Gubanski M; Lind PARM; Verheij M
• Article: RADIOTHERAPY AND ONCOLOGY. 2010;95(3):292-297

  Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

  Gunnlaugsson A; Anderson H; Lind P; Glimelius B; Johnsson A
• Published conference paper: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2010;704(1-3):160-166

  Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue

  Braeuer-Krisch E; Serduc R; Siegbahn EA; Le Duc G; Prezado Y; Bravin A; Blattmann H; Laissue JA
• Article: PLOS ONE. 2010;5(2):e9028

  High-Precision Radiosurgical Dose Delivery by Interlaced Microbeam Arrays of High-Flux Low-Energy Synchrotron X-Rays

  Serduc R; Braeuer-Krisch E; Siegbahn EA; Bouchet A; Pouyatos B; Carron R; Pannetier N; Renaud L; Berruyer G; Nemoz C; Brochard T; Remy C; Barbier EL; Bravin A; Le Duc G; Depaulis A; Esteve F; Laissue JA
• Article: PHYSICS IN MEDICINE AND BIOLOGY. 2009;54(21):6711-6724

  Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose

  Serduc R; Bouchet A; Braeuer-Krisch E; Laissue JA; Spiga J; Sarun S; Bravin A; Fonta C; Renaud L; Boutonnat J; Siegbahn EA; Esteve F; Le Duc G
• Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2009;75(3):S213

  Importance of Dosimetric Factors and Co-variates on Pulmonary Radiological Changes after Local-regional Radiotherapy (LRRT) for Breast Cancer (BC)

  Lind PA; Blom-Goldman U; Svane G
• Article: MEDICAL PHYSICS. 2009;36(4):1128-1137

  MOSFET dosimetry with high spatial resolution in intense synchrotron-generated x-ray microbeams

  Siegbahn EA; Braeuer-Krisch E; Bravin A; Nettelbeck H; Lerch MLF; Rosenfeld AB
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2008;26(15):4579

  Final results of the randomized phase II study of sequential docetaxel and irinotecan with infusion 5-fluorouracil/folinic acid in patients with advanced gastric cancer - GA-TAC

  Lind PA; Gubanski M; Johnsson A; Fernebro E; Flygare P; Karlberg I; Kadar L; Glimelius B
• Article: PHYSICS IN MEDICINE AND BIOLOGY. 2008;53(5):1153-1166

  Characterization and quantification of cerebral edema induced by synchrotron x-ray microbeam radiation therapy

  Serduc R; de Looij YV; Francony G; Verdonck O; Van der Sanden B; Laissue J; Farion R; Braeuer-Krisch E; Siegbahn EA; Bravin A; Prezado Y; Segebarth C; Remy C; Lahrech H
• Article: PHYSICS IN MEDICINE AND BIOLOGY. 2008;53(4):861-878

  Irradiation of intracerebral 9L gliosarcoma by a single array of microplanar x-ray beams from a synchrotron:: balance between curing and sparing

  Regnard P; Le Duc G; Brauer-Krisch E; Tropres I; Siegbahn EA; Kusak A; Clair C; Bernard H; Dallery D; Laissue JA; Bravin A
• Journal article: JOURNAL OF PHYSICS: CONFERENCE SERIES. 2008;102(1):012005

  Monte Carlo code comparison of dose delivery prediction for microbeam radiation therapy

  De Felici M; Siegbahn EA; Spiga J; Hanson AL; Felici R; Ferrero C; Tartari A; Gambaccini M; Keyriläinen J; Bräuer-Krisch E; Randaccio P; Bravin A
• Published conference paper: ACTA ONCOLOGICA. 2008;47(3):413-420

  Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma

  Lind PA; Isaksson B; Almstrom M; Johnsson A; Albiin N; Bystrom P; Permert J
• Article: MEDICAL PHYSICS. 2007;34(11):4322-4330

  The GEANT4 toolkit for microdosimetry calculations:: Application to microbeam radiation therapy (MRT)

  Spiga J; Siegbahn EA; Braeuer-Krisch E; Randaccio P; Bravin A
• Article: LAKARTIDNINGEN. 2007;104(43):3214-3215

  [Adjuvant therapy of ventricular cancer tested in Sweden].

  Glimelius B; Lind P; Lundell L
• Conference publication: 2007;4:2571-2575

  Geant4 Simulations for Microbeam Radiation Therapy (MRT) Dosimetry

  Spiga J; Siegbahn EA; Bräuer-Krisch E; Randaccio P; Bravin A
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(18_suppl):15073

  Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma

  Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
• Article: RADIOTHERAPY AND ONCOLOGY. 2007;82(3):308-316

  Early clinical and radiological breast cancer radiation pulmonary complications following therapy: NTCP fit with four different models

  Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(18)

  Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma

  Lind PA; Isaksson B; Almstrom M; Johnsson A; Albiin N; Bystrom P; Permert J
• Review: ACTA ONCOLOGICA. 2007;46(3):277-285

  Advances in the treatment of patients with gastric adenocarcinoma

  Foukakis T; Lundell L; Gubanski M; Lind PA
• Article: ACTA ONCOLOGICA. 2007;46(2):230-233

  Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

  Lind PA; Naucler G; Holm A; Gubanski M; Svensson C
• Article: ACTA ONCOLOGICA. 2007;46(2):187-193

  Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer

  Blom-Goldman U; Svane G; Wennberg B; Lidestahl A; Lind PARM
• Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006;66(3):S487

  Heart changes on MRI and spect after definitive radiation therapy in patients with lung cancer

  Lind PA; Larsson T; Lidestahl A; Agren-Cronqvist A; Nygren A; Brodin O
• Conference publication: 2006;3:1363-1367

  Microdosimetry for Microbeam Radiation Therapy (MRT): theoretical calculations using the Monte Carlo toolkit

  Spiga J; Siegbahn EA; Bräuer-Krisch E; Randaccio P; Bravin A
• Article: MEDICAL PHYSICS. 2006;33(9):3248-3259

  Determination of dosimetrical quantities used in microbeam radiation therapy (MRT) with Monte Carlo simulations

  Siegbahn EA; Stepanek J; Brauer-Krisch E; Bravin A
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2006;24(18_suppl):17059

  Cardiac changes on MRI and SPECT after definitive radiotherapy in patients with lung cancer

  Lind PA; Larsson T; Lideståhl A; Thoren L; Ågren-Cronqvist A; Nygren AT; Brodin O
• Corrigendum: REVIEW OF SCIENTIFIC INSTRUMENTS. 2006;77(3):039901

  Characterization of a tungsten/gas multislit collimator (TMSC) for microbeam radiation therapy at the European Synchrotron Radiation Facility (vol 76, 064303, 2005) -: art. no. 039901

  Bräuer-Krisch E; Bravin A; Zhang L; Siegbahn E; Stepanek J; Blattmann H; Slatkin DN; Gebbers JO; Jasmin M; Laissue JA
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006;64(3):765-770

  ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer

  Lind PA; Wennberg B; Gagliardi G; Rosfors S; Blom-Goldman U; Lideståhl A; Svane G
• Letter: ACTA ONCOLOGICA. 2006;45(2):210-212

  Reassessment for radical surgery after palliative chemotherapy in locally advanced pancreatic carcinoma:: Two case-reports

  Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
• Review: ACTA ONCOLOGICA. 2006;45(2):136-143

  Efficacy of systemic therapy in advanced pancreatic carcinoma

  Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
• Editorial comment: ACTA ONCOLOGICA. 2006;45(1):13-15

  Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation

  Lind P
• Published conference paper: IEEE TRANSACTIONS ON NUCLEAR SCIENCE. 2005;52(6):2562-2569

  Edge-on face-to-face MOSFET for synchrotron microbeam dosimetry: MC modeling

  Rosenfeld AB; Siegbahn EA; Brauer-Krish E; Holmes-Siedle A; Lerch MLF; Bravin A; Cornelius IM; Takacs GJ; Painuly N; Nettelback H; Kron T
• Meeting abstract: RADIOTHERAPY AND ONCOLOGY. 2005;76:S48

  Radiation induced pulmonary complications in breast cancer patients clinically and radiologically scored: NTCP fit with four different models

  Gagliardi G; Rancati T; Wennberg B; Svane G; Lind P
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2005;63(1):214-223

  The incidence and functional consequences of RT-associated cardiac perfusion defects.

  Marks LB; Yu X; Prosnitz RG; Zhou S-M; Hardenbergh PH; Blazing M; Hollis D; Lind P; Tisch A; Wong TZ; Borges-Neto S
• Published conference paper: NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT. 2005;548(1-2):69-71

  Exploiting geometrical irradiation possibilities in MRT application

  Bräuer-Krisch E; Requardt H; Régnard P; Corde S; Siegbahn EA; LeDuc G; Blattmann H; Laissue J; Bravin A
• Published conference paper: NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT. 2005;548(1-2):54-58

  Dosimetric studies of microbeam radiation therapy (MRT) with Monte Carlo simulations

  Siegbahn EA; Bräuer-Krisch E; Stepanek J; Blattmann H; Laissue JA; Bravin A
• Article: PHYSICS IN MEDICINE AND BIOLOGY. 2005;50(13):3103-3111

  New irradiation geometry for microbeam radiation therapy

  Bräuer-Krisch E; Requardt H; Régnard P; Corde S; Siegbahn E; LeDuc G; Brochard T; Blattmann H; Laissue J; Bravin A
• Article: REVIEW OF SCIENTIFIC INSTRUMENTS. 2005;76(6):064303

  Characterization of a tungsten/gas multislit collimator for microbeam radiation therapy at the European Synchrotron Radiation Facility -: art. no. 064303

  Bräuer-Krisch E; Bravin A; Zhang L; Siegbahn E; Stepanek J; Blattmann H; Slatkin DN; Gebbers JO; Jasmin M; Laissue JA
• Published conference paper: ACTA ONCOLOGICA. 2005;44(3):236-239

  Capecitabine as third line therapy in patients with advanced colorectal cancer

  Gubanski M; Naucler G; Almerud A; Lideståhl A; Lind PARM
• Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2004;60(1):S401

  Effect of dose-volume constraints on pneumonitis in loco-regional breast cancer irradiation

  Blom-Goldman U; Anderson M; Wennberg B; Svane G; Lind P
• Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2004;60:s401

  Effect of dose-volume constraints on pneumonitis in loco-regional breast cancer irradiation

  BLOMGOLDMAN U; ANDERSON M; WENNBERG B; SVANE G; LIND P
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(14_suppl):693

  Prevention of radiation pneumonitis in breast cancer irradiation through dose-volume constraint

  Lind P; Blom-Goldman U; Anderson M; Wennberg B; Svane G
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(14_suppl):693

  Prevention of radiation pneumonitis in breast cancer irradiation through dose-volume constraint

  Lind P; Blom-Goldman U; Anderson M; Wennberg B; Svane G
• Conference publication: BREAST CANCER RESEARCH AND TREATMENT. 2004;88:S173

  Assessment of pneumonitis in loco-regional breast cancer irradiation.

  Blom-Goldman U; Andersson M; Wennberg B; Svane G; Lind P
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(14):50S

  Prevention of radiation pneumonitis in breast cancer irradiation through dose-volume constraints.

  Lind P; Blom-Goldman U; Anderson M; Wennberg B; Svane G
• Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2003;57(2):s130

  ROC-curves and evaluation of radiation-induced side-effects in breast cancer

  Lind PA; Wennberg B; Gagliardi G; Rosfors S; Svane G
• Article: PHYSICS IN MEDICINE AND BIOLOGY. 2003;48(10):1263-1275

  Calculations of electron fluence correction factors using the Monte Carlo code PENELOPE

  Siegbahn EA; Nilsson B; Fernández-Varea JM; Andreo P
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2003;55(5):1196-1199

  Breast conservation rates-barriers between tertiary care and community practice.

  Hahn CA; Marks LB; Chen DY; Lind PA; Lind HM; Prosnitz LR
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2003;55(4):914-920

  Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution.

  Lind PA; Pagnanelli R; Marks LB; Borges-Neto S; Hu C; Zhou SM; Light K; Hardenbergh PH
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;54(2):340-347

  Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.

  Lind PA; Marks LB; Hollis D; Fan M; Zhou S-M; Munley MT; Shafman TD; Jaszczak RJ; Coleman RE
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;53(4):835-846

  Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer.

  Etiz D; Marks LB; Zhou S-M; Bentel GC; Clough R; Hernando ML; Lind PA
• Article: CANCER. 2002;94(11):2821-2829

  Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.

  Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;52(5):1196-1206

  Early response of lung in breast cancer irradiation: Radiologic density changes measured by CT and symptomatic radiation pneumonitis

  Wennberg B; Gagliardi G; Sundbom L; Svane G; Lind P
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;52(1):137-143

  Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer.

  Lind PARM; Marks LB; Hardenbergh PH; Clough R; Fan M; Hollis D; Hernando ML; Lucas D; Piepgrass A; Prosnitz LR
• Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(3):157-158

  Myocardial perfusion changes in patients treated for left-sided breast cancer and correlation with coronary artery distribution

  Lind PA; Pagnanelli R; Marks LB; Hu C; Borges-Neto S; Hardenbergh PH
• Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(3):51

  Breast conservation rates - barriers between tertiary care and community practice

  Hahn CA; Marks LB; Chen DY; Lind PA; Lind HM; Prosnitz LR
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(3):650-659

  Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.

  Hernando ML; Marks LB; Bentel GC; Zhou SM; Hollis D; Das SK; Fan M; Munley MT; Shafman TD; Anscher MS; Lind PA
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(2):311-317

  Relating radiation-induced regional lung injury to changes in pulmonary function tests.

  Fan M; Marks LB; Lind P; Hollis D; Woel RT; Bentel GG; Anscher MS; Shafman TD; Coleman RE; Jaszczak RJ; Munley MT
• Article: BREAST CANCER RESEARCH AND TREATMENT. 2001;68(3):199-210

  Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose

  Lind PARM; Wennberg B; Gagliardi G; Fornander T
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;50(2):421-425

  A practical and easy method to locate the first three internal mammary lymph node-bearing areas.

  Marks LB; Bentel GC; Hardenbergh PH; Lind PA; Prosnitz LR
• Article: EUROPEAN RADIOLOGY. 2000;10(3):484-489

  Abnormalities on chest radiographs following radiation therapy for breast cancer

  Lind PARM; Bylund H; Wennberg B; Svensson C; Svane G
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2000;46(2):373-381

  Radiation pneumonitis after breast cancer irradiation:: Analysis of the complication probability using the relative seriality model

  Gagliardi G; Bjöhle J; Lax I; Ottolenghi A; Eriksson F; Liedberg A; Lind P; Rutqvist LE
• Doctoral thesis: 1999

  Short-term pulmonary side-effects following radiation therapy in breast cancer

  Lind P
• Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1999;43(3):489-496

  Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer

  Lind PARM; Svane G; Gagliardi G; Svensson C
• Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1999;45(3):316-317

  2075 Pulmonary side-effects following radiotherapy in breast cancer and the association to irradiated lung volume

  Lind PA; Wennberg B; Svensson C; Fornander T
• Article: RADIOTHERAPY AND ONCOLOGY. 1998;49(3):245-254

  Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning.

  Lind PA; Rosfors S; Wennberg B; Glas U; Bevegård S; Fornander T
• Article: ACTA ONCOLOGICA. 1997;36(5):509-515

  A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer

  Lind PARM; Gagliardi G; Wennberg B; Fornander T
• Visa fler

Medarbetare och kontakt

Gruppledare

• Sakarias Johansson

  Adjungerad Adjunkt

  E-postadress sakarias.johansson@ki.se
• David Kudrén

  E-postadress david.kudren@ki.se
• Chunde Li

  Anknuten till Forskning | Docent

  E-postadress chunde.li@ki.se
• Anders Lideståhl

  Anknuten till Forskning

  E-postadress anders.lidestahl@ki.se
• 

  Pehr Lind

  Anknuten till Forskning | Docent

  E-postadress pehr.lind@ki.se
• 

  Albert Siegbahn

  Adjungerad Lektor | Docent

  E-postadress albert.siegbahn@ki.se
• Camilla Wendt

  Anknuten till Forskning

  E-postadress camilla.wendt@ki.se

Alla medarbetare i gruppen

• 

  Shabane Barot

  Doktorand

  E-postadress shabane.barot@ki.se
• Sakarias Johansson

  Adjungerad Adjunkt

  E-postadress sakarias.johansson@ki.se
• David Kudrén

  E-postadress david.kudren@ki.se
• Chunde Li

  Anknuten till Forskning | Docent

  E-postadress chunde.li@ki.se
• Anders Lideståhl

  Anknuten till Forskning

  E-postadress anders.lidestahl@ki.se
• 

  Pehr Lind

  Anknuten till Forskning | Docent

  E-postadress pehr.lind@ki.se
• 

  Albert Siegbahn

  Adjungerad Lektor | Docent

  E-postadress albert.siegbahn@ki.se
• Camilla Wendt

  Anknuten till Forskning

  E-postadress camilla.wendt@ki.se

Andra personer med koppling till gruppen

• Dahlstedt, Love
• Hasslow, Johan
• Lagerbäck, Cecilia
• Schedin, Anna
• Viktor, Winther
• Winemar, Maria

Besöksadress

Department of Oncology, Sodersjukhuset, Department of Oncology, Sjukhusbacken 10, Stockholm, Stockholm, 11883, Sverige; Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige; Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige

Postadress

Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige; Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige; Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige; Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige